Hans Kristian Moen Vollan

Hans Kristian Moen Vollan

UNVERIFIED PROFILE

Are you Hans Kristian Moen Vollan?   Register this Author

Register author
Hans Kristian Moen Vollan

Hans Kristian Moen Vollan

Publications by authors named "Hans Kristian Moen Vollan"

Are you Hans Kristian Moen Vollan?   Register this Author

27Publications

959Reads

28Profile Views

The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer.

PLoS One 2015 13;10(10):e0139965. Epub 2015 Oct 13.

Department of Cancer Genetics, Institute for Cancer Research, Division of Cancer Medicine, Surgery and Transplantation, Radiumhospitalet-Oslo University Hospital, 0424 Oslo, Norway.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0139965PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4603798PMC
June 2016

Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumors.

Endocr Relat Cancer 2015 Dec 23;22(6):953-67. Epub 2015 Sep 23.

Laboratory for Functional GenomicsFondation Jean Dausset - Centre d'Etude du Polymorphisme Humain (CEPH), Paris, FranceInstitute of BiomedicineAarhus University, Aarhus, DenmarkEndocrine and Metabolic Surgery DepartmentAP-HM La Conception, Marseille, FranceDepartment of EndocrinologyAP-HM La Timone, Marseille, FranceDepartment of GeneticsInstitute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, NorwayDivision of SurgeryTransplantation and Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, NorwayThe K G Jebsen Center for Breast Cancer ResearchInstitute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayPathology DepartmentAP-HM La Timone, Marseille, FranceNuclear Endocrine Imaging and Treatment DepartmentAP-HM La Timone, Marseille, FranceCancer Research UKLondon Research Institute, London, UKDepartment of Human GeneticsUniversity of Leuven, Leuven, BelgiumGenotyping FacilitiesCentre National de Génotypage, CEA-Institut de Génomique, Evry, FranceDepartment of Clinical Molecular Biology (EpiGen)University of Oslo, Ahus, Lokerod, NorwayLaboratory of Molecular BiologyAP-HM La Conception and CRN2M, Aix-Marseille University, Marseille, FranceLaboratory for Epigenetics and EnvironmentCentre National de Génotypage, CEA-Institut de Génomique, Evry, France

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/ERC-15-0086DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621769PMC
December 2015

Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer.

Genome Med 2015 2;7(1):21. Epub 2015 Feb 2.

Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, 0310 Norway ; K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, University of Oslo, Oslo, 0316 Norway ; Department of Clinical Molecular Biology and Laboratory Science (EpiGen), Division of Medicine, Akershus University Hospital, Lørenskog, 1478 Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13073-015-0135-5DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4396592PMC
April 2015

Lymphocyte Invasion in IC10/Basal-Like Breast Tumors Is Associated with Wild-Type TP53.

Mol Cancer Res 2015 Mar 28;13(3):493-501. Epub 2014 Oct 28.

Department of Genetics, Institute for Cancer Research, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. K.G. Jebsen Centre for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway. Department of Clinical Molecular Oncology, Division of Medicine, Akershus University Hospital, Ahus, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1541-7786.MCR-14-0387DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465579PMC
March 2015

A tumor DNA complex aberration index is an independent predictor of survival in breast and ovarian cancer.

Mol Oncol 2015 Jan 8;9(1):115-27. Epub 2014 Aug 8.

Cancer Research UK, Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Robinson Way, Cambridge CB2 0RE, UK; Department of Oncology, University of Cambridge, Hills Road, Cambridge CB2 2XZ, UK; Cambridge Experimental Cancer Medicine Centre, Cambridge CB2 0RE, UK; Cambridge Breast Unit, Addenbrooke's Hospital, Cambridge University Hospital NHS Foundation Trust and NIHR Cambridge Biomedical Research Centre, Cambridge CB2 2QQ, UK. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.07.019DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4286124PMC
January 2015

TP53 mutation spectrum in breast cancer is subtype specific and has distinct prognostic relevance.

Clin Cancer Res 2014 Jul 6;20(13):3569-80. Epub 2014 May 6.

Authors' Affiliations: Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet; The K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2943DOI Listing
July 2014

JARID1B is a luminal lineage-driving oncogene in breast cancer.

Cancer Cell 2014 Jun;25(6):762-77

Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, MA 02215, USA; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Department of Medicine, Harvard Medical School, Boston, MA 02115, USA; Broad Institute, Cambridge, MA 02141, USA; Harvard Stem Cell Institute, Cambridge, MA 02138, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccr.2014.04.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4079039PMC
June 2014

The 5p12 breast cancer susceptibility locus affects MRPS30 expression in estrogen-receptor positive tumors.

Mol Oncol 2014 Mar 3;8(2):273-84. Epub 2013 Dec 3.

Department of Genetics, Institute for Cancer Research, Oslo University Hospital Radiumhospitalet, Oslo, Norway; K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Clinical Molecular Biology (EpiGen), Medical Division, Akershus University Hospital, Lørenskog, Norway. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2013.11.008DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964809PMC
March 2014

Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status.

BMC Cancer 2014 Mar 19;14:211. Epub 2014 Mar 19.

Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Montebello 0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-14-211DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000128PMC
March 2014

Triple-negative breast cancer and the need for new therapeutic targets.

Am J Pathol 2013 Oct 3;183(4):1064-1074. Epub 2013 Aug 3.

K.G. Jebsen Center for Breast Cancer Research, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Department of Genetics, Institute for Cancer Research, Oslo University Hospital, The Norwegian Radium Hospital, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2013.05.033DOI Listing
October 2013

The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells.

Mol Oncol 2013 Jun 24;7(3):392-401. Epub 2012 Nov 24.

Department of Genetics, Institute for Cancer Research, Division of Surgery and Cancer, Oslo University Hospital, Radiumhospitalet, 0310 Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2012.10.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528495PMC
June 2013

Analyzing cancer samples with SNP arrays.

Methods Mol Biol 2012 ;802:57-72

Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-61779-400-1_4DOI Listing
April 2012

Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue.

Mol Oncol 2011 Dec 29;5(6):564-76. Epub 2011 Aug 29.

Department of Genetics, Institute of Cancer Research, Oslo University Hospital, Radiumhospitalet, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2011.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5528325PMC
December 2011

The breast cancer genome--a key for better oncology.

BMC Cancer 2011 Nov 30;11:501. Epub 2011 Nov 30.

Breast Cancer Functional Genomics, Cancer Research UK Cambridge Research Institute, Cambridge, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-11-501DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3268769PMC
November 2011